“Biochip development continued during the Quarter with a biosensing graphene transistor
design sent to a commercial foundry to make the devices on a multi-project wafer. The goal is
to optimise the design and then select the design that works the best and can be easily scaled
up for commercial production. By the end of 2023, the Company should receive the first batch
of chips from the foundry.”
Ann: Quarterly Activity Report & Appendix 4C, page-9
Add AXE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.0¢ |
Change
0.010(2.56%) |
Mkt cap ! $101.9M | |||
| Open | High | Low | Value | Volume |
| 40.0¢ | 41.0¢ | 39.5¢ | $56.03K | 140.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 4000 | 39.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.5¢ | 2548 | 2 |
View Market Depth
| Last trade - 12.57pm 06/06/2024 (20 minute delay) ? |
|
|||||
|
Last
40.5¢ |
Change
0.010 ( 1.25 %) |
||||
| Open | High | Low | Volume | ||
| 40.5¢ | 41.0¢ | 39.0¢ | 95470 | ||
| Last updated 13.33pm 06/06/2024 ? | |||||
| AXE (ASX) Chart |